Cite

HARVARD Citation

    Busque, S. et al. (2018). Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation. Transplantation direct. 4 (9), p. . [Online]. 
  
Back to record